ENGN ▲ +2.2% - enGene Therapeutics Inc.
$ENGN Leerink analyst Lili Nsongo upgraded enGene to Outperform from Market Perform with a $5 price target.
13-NOV-2026 08:23 AM ET
Share this post
More filings for $ENGN
ENGN ▲ +20.6% - enGene Therapeutics Inc.Nov 12, 2026ENGN ▲ +10.2% - enGene Therapeutics Inc.Nov 11, 2026ENGN - enGene Therapeutics Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026ENGN - enGene Therapeutics Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026ENGN - enGene Therapeutics Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026ENGN - enGene Therapeutics Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $ENGN filing history →💬 Comments
Loading comments…
Leave a comment